EULAR 2008 - Rheumatoid Arthritis : Anti-TNF Therapy
The Annual European Congress of Rheumatology was held in Paris, France from June 11-14, 2008. This is the official meeting of the European League Against Rheumatism (EULAR). Full abstract reports may be can be found online by visiting the EULAR Congress website. While it is not possible to review all of the important findings from these meetings, some selected highlights are summarized. These highlights focus on Rheumatoid Arthritis. The highlights are summarized by Joan Bathon, M.D. and Jon Giles, M.D.
- LB-0001 In Patients with Early RA who Failed Initial MTX, the Addition of Anti-TNF Yields Better EULAR and ACR Responses than the Additional of Conventional DMARDs: 1-Year Results of the SWEFOT Clinical Trial
- OP-0121 Safety, Local Tolerability and Clinical Response after Intra-Articular Administration of a Recombinant Adeno-Associated Vector Containing a TNF Antagonist Gene in Inflammatory Arthritis.
